Related Experiment Video
Updated: Jul 15, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia
Nesrin Damla Karakaplan1, Yilin Song1, Marcello C Laurenti1
1Endocrine Research Unit, Division of Endocrinology, Diabetes and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
Exogenous hyperinsulinemia suppresses insulin secretion in humans. This effect was observed in both nonobese and obese individuals, with no significant difference in the proportional suppression between groups.
Area of Science:
- Endocrinology
- Metabolic Research
- Human Physiology
Background:
- The effect of exogenous hyperinsulinemia on endogenous insulin secretion is not fully understood.
- Investigating this impact is crucial for understanding glucose homeostasis and insulin resistance.
Purpose of the Study:
- To determine how exogenous hyperinsulinemia affects insulin secretion in humans.
- To examine if insulin resistance, associated with obesity, alters this response.
Main Methods:
- Utilized euglycemic hyperinsulinemic clamp studies in 52 volunteers.
- Calculated insulin secretion rates (ISRs) using plasma C-peptide concentrations and a mathematical model.
- Assessed the percent change in ISR from fasting to hyperinsulinemic conditions.
Main Results:
- Insulin secretion rates (ISRs) were higher in obese volunteers under both fasting and clamp conditions.
- A 27% suppression of ISR was observed during hyperinsulinemia.
- The proportional suppression of ISR did not significantly differ between nonobese and obese groups.
Conclusions:
- Exogenous hyperinsulinemia effectively suppresses endogenous insulin secretion.
- Obesity does not alter the relative suppression of insulin secretion induced by hyperinsulinemia.
More Related Videos
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Hypoglycemia and Glucagon
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Secretory Vesicles